Advertisement
UK markets close in 3 hours 1 minute
  • FTSE 100

    7,953.53
    +21.55 (+0.27%)
     
  • FTSE 250

    19,861.05
    +50.39 (+0.25%)
     
  • AIM

    743.08
    +0.97 (+0.13%)
     
  • GBP/EUR

    1.1688
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2633
    -0.0005 (-0.04%)
     
  • Bitcoin GBP

    56,131.86
    -330.98 (-0.59%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CRUDE OIL

    82.46
    +1.11 (+1.36%)
     
  • GOLD FUTURES

    2,232.20
    +19.50 (+0.88%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • DAX

    18,492.34
    +15.25 (+0.08%)
     
  • CAC 40

    8,224.84
    +20.03 (+0.24%)
     

McKesson (MCK) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, McKesson (MCK) closed at $389.22, marking a +1.2% move from the previous day. This move outpaced the S&P 500's daily gain of 0.62%. Elsewhere, the Dow gained 0.5%, while the tech-heavy Nasdaq lost 5.66%.

Prior to today's trading, shares of the prescription drug distributor had lost 2.49% over the past month. This has was narrower than the Medical sector's loss of 2.88% and lagged the S&P 500's gain of 3.44% in that time.

Investors will be hoping for strength from McKesson as it approaches its next earnings release. In that report, analysts expect McKesson to post earnings of $5.85 per share. This would mark year-over-year growth of 0.34%. Our most recent consensus estimate is calling for quarterly revenue of $69.56 billion, up 3.58% from the year-ago period.

MCK's full-year Zacks Consensus Estimates are calling for earnings of $26.56 per share and revenue of $294.4 billion. These results would represent year-over-year changes of +2.39% and +6.39%, respectively.

ADVERTISEMENT

Investors should also note any recent changes to analyst estimates for McKesson. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.

Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.19% lower. McKesson is currently a Zacks Rank #3 (Hold).

Digging into valuation, McKesson currently has a Forward P/E ratio of 14.48. This represents a discount compared to its industry's average Forward P/E of 21.06.

We can also see that MCK currently has a PEG ratio of 1.34. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 2.09 based on yesterday's closing prices.

The Medical - Dental Supplies industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 63, which puts it in the top 25% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow MCK in the coming trading sessions, be sure to utilize Zacks.com.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

McKesson Corporation (MCK) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research